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Abstract 
Neuroblastoma is the third most common malignancy of childhood, after leukemia 
and brain tumors. Only 2% of all neuroblastoma occur in the brain. Primary 
cerebellar neuroblastoma is an specific subset of Primitive Neuroectodermal 
Tumors (PNET). Meduloblastoma is a relatively common and well-established 
entity, consisting of primitive and multipotential cells that may exhibit some 
evidence of neuroblastic or gliad differentiation. But cerebellar neuroblastoma 
with ultrastractural evidence of significant neuroblastic differentiation is 
extremely rare. We report a rare case of neuroblastoma in the cerebellum. A 
2.5-year-old Iranian boy presented with vomiting and nausea in the morning and 
ataxia. CT scan showed a tumor mass in the cerebellum and the report of 
radiologist was medulloblastoma. Light microscopic assay showed a small cell 
neoplasm with lobules of densely packed cells (lobulated pattern) and better 
differentiated cells. Neuron-Specific Enolase was positive. Pathologic diagnosis 
confirmed the existence of cerebellar neuroblastoma. Chemotherapy followed 
surgical removal. No relapse occurred 12 months after surgery.  
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Introduction 
    Neroblastoma is the most common extracranial 
solid tumor in children, accounting for 8% to 10% of 
all childhood cancers [1-4]. 
A tumor mass can occur anywhere along the 
sympathetic nerve crest pathway [2]. 
Therefore, a wide variety of tumor locations and 
clinical presentations have been described [5] but 
only 2% of all nerublastoma arise in the brain [6]. 
The most common malignant brain tumor of childhood 
is Medulloblastoma [1, 2]. Medulloblastoma, 
medullophithelioma, and neuroblastoma are 
designated in the WHO classification as embryonic 
and cytologically pluripotential tumors. 
Microscopically, medulloblastomas exhibit highly 
variable histological features, most frequently 
appearing as an infiltrative, extremely 
undifferentiated, cellular neoplasm [3, 5]. The cells 
have carrot - shaped or ovoid nuclei   with course 
dark chromatin and scant or no visible cytoplasm. 
Mitoses and necrosis are highly variable. Homer – 
wright rosettes, the core of which is formed or 
tenuous fibrillated processes, may be present. 
Exceptionally, neurons in various stages of maturation 
are observed. When matured cells are present at the  
site of cerebellum, the tumor maybe classified as 
cerebellar ganglioneuroblastoma. 
 When they form a lobulated pattern with cells 
streaming in a fine fibrillated background, they are 
designated cerebellar neuroblastoma [1, 7, 8]. 
Review of epidemiologic studies and case reports 
revealed that there is not a reported case of 
cerebellar neuroblastoma as a primary CNS tumor in 
Iran [9-11]. Here, we describe a rare case with 
cerebellar mass, which pathological diagnosis was 
cerebellar neuroblastoma.  
 
Case Report  
    We report a patient with primary cerebellar 
neuroblastoma. A 2.5-year-old boy was admitted to 
our hospital because of nausea and vomiting in the 
morning, headache, ataxia, poor balance and 
torticulli. The preoperative routine complete blood 
count , clotting profiles , electrolytes , sequential 
multiple analysis for chemistry , and the urine 
analysis findings were all within the normal limits . A 
brain CT scan revealed a well defined hyperdense 
mass in cerebellar vermis compressing forth ventricle 
with obstructive hydrocephaly, compatible with 
medulloblastoma (Figure 2).  A microscopic 
suboccipital craniectomy was performed and after 
complete resection of the tumor, a 
ventriculoperitoneal shunt was inserted.  
The pathologist reported a lesion composed of small, 
dense and round cells with hyperchromatic nucleus 
and scanty cytoplasm. The lesion arranged in sheets 
and prevascular accumulation numerous foci of small 
cells with few mitotic figures. There were necrosis and 
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hemorrhagia. Also lobulated tumor cells were 
arranged in groups (islands separated by few 
fibrous stroma). Parallel patterns were seen in some 
foci of tumor cells. Also cells with vesicular nuclei 
were seen (Figure 2). These findings established the 
diagnosis of neuroblastoma. Immuno-Histo-Chemistry 
(IHC) showed a strong positivity for Neuron-Specific 
Enolase (NSE). 
During this hospital admission, postoperative systemic 
examination which included bone survey, bone 
marrow aspiration, abdomino-pelvic CT scan and 
MRI of the neuroaxis revealed no other evidence of 
tumor. Also cytological examination of cerebrospinal 
fluid was normal. After surgery we began 
chemotherapy with a combination of Cisplatin, Ara-c, 
Vincristine, Hydroxyurea, Lamustin, Procarbazin, 
Cyclophosphamide and Methyl prednisolon (8 at 1 
protocol) every four weeks for 12 courses. Follow up 
examination revealed a profound delay in mental 
development but brain MRI performed 12 months 
after surgery revealed no evidence of tumor 
recurrence. The patient is presently 3.5 years old 
and his chemotherapy is finished and he is stable 
with no sign of relapse. 
 
 
                
Figure 1.This figure shows                                                Figure 2. This figure shows pathological slide  
brain CT scan at the time of diagnosis.                 of tumor (H&E staining). 
 
Discussion  
    Neuroblastoma is an enigmatic tumor in its clinical 
and biologic behavior [1]. Emberyonal tumors or 
Primitive Neuroectodermal Tumors ( PNET ) are the 
most common groups of malignant CNS tumors of 
childhood, accounting for 20 – 25 % of pediatric 
CNS tumors [3]. Primitive neuroepithelial tumors of 
the CNS, with few or absent foci of cellular 
differentiation, are called primary cerebral 
neuroblstoma or medulloblastoma depending on a 
supra–or infratentorial location of the mass, 
respectively [1]. A wide variety of tumors are known 
to occur in the cerebellum and many of these are 
referred to as medulloblastoma [12]. 
Medulloblastoma, accounting for 90% of embryonal 
tumors, is a cerebellar tumor [4]. Their cells are 
primitive or poorly differentiated and are 
considered to be of embryonic origin [13]. Its 
differentiating capacity is one of disputes. Many 
researchers have not observed the ultrastructural 
characteristics of neuronal differentiation in 
medulloblastoma [13]. Yagishita et al. examined a 
series of medulloblastomas by histological and 
immunohistochemical techniques and proposed the 
hypothesis that medulloblastoma was a stem–cell 
lines, astrocytic, ependymall, neuronal and 
oligodendroglial although "cerebellar 
neuroblastoma" could arise from differentiation of a 
medulloblastoma along neuroblastic lines [14,15]. 
Cerebellar "neuroblastomas" are extremely rare 
[15]. There are a few reports of cerebellar 
neuroblastoma in the papers. Shuji Nishio et al. 
(2000) reported a case of cerebellar neuroblastoma 
in an infant separately. This tumor displays a better 
prognosis than those with classical or desmoplastic 
medulloblastoma. The optimal treatment for patients 
with this tumor, however, remains uncertain. This 
tumor tends to occur in young children particularly in 
infants, and this further makes the treatment 
problematic [16]. Our patient was treated by total 
removal of the tumor followed by chemotherapy. He 
was survived one year after operation without 
recurrence.  
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